Nuvo Pharmaceuticals Inc (MRVFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Sales | 20,420 | 16,731 | 11,830 | 4,300 | 0 |
| Cost of Goods | 8,577 | 8,052 | 5,010 | 4,630 | N/A |
| Gross Profit | 11,843 | 8,679 | 6,810 | -320 | N/A |
| Operating Expenses | 6,689 | 15,430 | 19,050 | 17,270 | 0 |
| Operating Income | 5,731 | -6,698 | -12,220 | -16,970 | N/A |
| Interest Expense | 0 | 31 | 640 | 630 | 0 |
| Other Income | -135 | 1,156 | 47,840 | 7,640 | 0 |
| Pre-tax Income | 5,595 | -5,574 | 34,980 | -9,960 | 0 |
| Income Tax | 0 | 6 | 10 | 110 | N/A |
| Net Income Continuous | 5,595 | -5,579 | -12,092 | -3,905 | N/A |
| Net Income Discontinuous | -2,402 | N/A | 0 | 0 | N/A |
| Net Income | $3,194 | $-5,579 | $34,960 | $-10,080 | $N/A |
| EPS Basic Total Ops | 0.28 | -0.51 | 3.39 | -1.15 | N/A |
| EPS Basic Continuous Ops | 0.49 | -0.51 | -1.21 | -0.44 | N/A |
| EPS Basic Discontinuous Ops | -0.21 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.27 | -0.51 | 3.31 | -1.15 | N/A |
| EPS Diluted Continuous Ops | 0.48 | -0.51 | -1.18 | -0.44 | N/A |
| EPS Diluted Discontinuous Ops | -0.21 | N/A | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | 0.48 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $5,906 | $-6,453 | $-11,580 | $-15,680 | $N/A |